Stop TB Partnership Website

 

Global Laboratory Initiative


Home | Mission and Strategic Priorities | History | Structure and Governance | Meetings | Resources | FAQ | Contact Us

What's new?

Expanding and accelerating access to diagnostics for patients at risk of MDR-TB

Narrowing the Gap: Expanding and accelerating access to diagnostics for patients at risk of multi-drug resistant tuberculosis (MDR-TB)

<< March 2010 >>
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31

Structure and Governance

The GLI constitutes a global network of partners dedicated to TB laboratory strengthening at global, regional and country levels.

Figure 1: GLI structure and functions


Current GLI partners:

American Society for Microbiology (ASM)
Association of Public Health Laboratories (APHL)
Bill & Melinda Gates Foundation
Centers for Disease Control and Prevention (CDC)
CDC Global AIDS Programme (GAP)
Fondation Merieux
Foundation for Innovative New Diagnostics (FIND)
International Union Against TB and Lung Disease
PEPFAR
USAID
KNCV Ministries of Health, through National TB Control Programmes
Merieux Alliance
Management Sciences for Health (MSH)
Medecins Sans Frontiers
Stop TB Partnership Working Groups (New Diagnostics, MDR-TB, Retooling Task Force, DOTS Expansion)
National TB Programmes
WHO
Johns Hopkins University, US
GHESKIO
GTZ
KfW Bank, Germany
Partners in Health, US
Project Hope
ICRC
The Global Fund
The Union
WHO-Union Supranational TB Reference Laboratory Network